Sigolis has a certified development process that leads to the goal.
B2B product development
With product specifications from our clients we develop the processes and technology to reach the requirements.
Sigolis is involved in basic research projects with academic partners in the European arena.
The BLUEPRINT Consortium was assembled with the aim of bringing together the most competitive and complementary European groups able to generate and analyse the epigenomes of haematopoietic cells in health and disease. The consortium consists of 41 partner organisations, representing 43 academic groups and 9 companies, SMEs from 11 countries.